Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1

作者：Sieben Maike; Schaefer Petra; Dinsart Christiane; Galle Peter R; Moehler Markus^*

来源：International Journal of Cancer, 2013, 132(11): 2548-2556.

DOI：10.1002/ijc.27938

• autonomous parvovirus
• dendritic cells
• toll-like receptors
• nuclear factor-kappaB

This study aimed to investigate the function of toll-like receptors (TLRs) during oncolytic parvovirus H-1 (H-1PV)-induced human immune responses. First, the role of TLRs in the activation of the NFB transcription factor was characterized; second, the immunologic effects of H-1PV-induced tumor cell lysates (TCL) on human antitumor immune responses were evaluated. A human ex vivo model was used to study immune responses with dendritic cells (DCs). Human embryonic kidney cells (HEK293) transfected to stably express TLRs were used as potential human DC equivalents to further investigate the role of specific TLRs during immune activation. TLR3 and TLR9 were activated by H-1PV infection, which correlated with NFB translocation to the nucleus and a reduced cytoplasmic IB expression. Using a TLR-signaling reporter plasmid (pNiFty-Luc), NFB activity was increased following H-1PV infection. In addition, human DCs coincubated with H-1PV-induced TCL demonstrated increased TLR3 and TLR9 expression. These data suggest that H-1PV-induced TCL stimulate human DCs at least in part through TLR-dependent signaling pathways. Thus, DC maturation occurred through exposure to H-1PV-induced TCL through TLR-signaling leading to NFB-dependent activation of the adaptive immune system as indicated by the increased expression of CD86, TLR3 and TLR9. Furthermore, the transcription of various cytokines indicates the activation of immune response, therefore the production of the proinflammatory cytokine TNF- was determined. Here, H-1PV-induced TCL significantly enhanced the TNF- level by DCs after coculture. H-1PV oncolytic virotherapy enhances immune priming by different effects on DCs and generates antitumor immunity. These findings potentially offer a new approach to tumor therapy.

• 出版日期2013-6-1